Balanced news tone
News Sentiment
PHAR sentiment intelligence
Pharming Group NV news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
47 relevant articles
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
+0.7% over one week, +8.2% over four weeks, trend inactive, and near fair-value range.
Pharming Group to report Q2 and H1 2026 results on July 30
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
75/100 classification
One-week reaction
0.7%
Price digesting
Trend fit
Trend inactive
8.2% over four weeks
Fair value
18.6%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
10
Neutral
34
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
GlobeNewswire
Direct company coverage
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 05:00
- Source
- GlobeNewswire
GlobeNewswire
Direct company coverage
Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- GlobeNewswire
GlobeNewswire
Direct company coverage
Pharming Group announces results of 2026 Annual General Meeting of Shareholders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 May 2026 07:00
- Source
- GlobeNewswire
MT Newswires
Direct company coverage
Pharming Says European Commission Grants Marketing Authorization to Joenja
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 19:59
- Source
- MT Newswires
GlobeNewswire
Direct company coverage
European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 19:30
- Source
- GlobeNewswire
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
simplywall.st
Industry context
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
Pharming Group reports first quarter 2026 financial
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- GlobeNewswire
Seeking Alpha
Direct company coverage
Pharming Group N.V. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:PHAR) 2026-05-07
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Seeking Alpha
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Seeking Alpha
Direct company coverage
Pharming Group: Crossing From Speculation To Profitability (NASDAQ:PHAR)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Seeking Alpha
Stocktwits
Direct company coverage
Nasdaq, S&P 500 Futures Open Week In The Red As Gold, Silver Extend Sharp Selloff: Why ORCL, PLTR, DIS, PHAR, ELPW Are On Traders' Radar Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- Stocktwits
Investing.com UK
Direct company coverage
Pharming Group stock tumbles after FDA issues Complete Response Letter By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- Investing.com UK